GAMMA Investing LLC Has $42,000 Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

GAMMA Investing LLC raised its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 57.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 663 shares of the company’s stock after buying an additional 241 shares during the quarter. GAMMA Investing LLC’s holdings in Acadia Healthcare were worth $42,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ACHC. Point72 Asset Management L.P. boosted its holdings in Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares during the last quarter. Millennium Management LLC raised its stake in shares of Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after buying an additional 1,055,894 shares during the period. William Blair Investment Management LLC raised its stake in Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after acquiring an additional 604,070 shares during the period. Vaughan Nelson Investment Management L.P. lifted its stake in shares of Acadia Healthcare by 67.9% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company’s stock valued at $49,541,000 after buying an additional 296,625 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in Acadia Healthcare by 59.3% during the 1st quarter. Principal Financial Group Inc. now owns 539,162 shares of the company’s stock valued at $42,712,000 after acquiring an additional 200,765 shares during the period.

Acadia Healthcare Trading Up 3.4 %

ACHC stock opened at $59.32 on Friday. Acadia Healthcare Company, Inc. has a one year low of $53.22 and a one year high of $87.77. The company has a market capitalization of $5.50 billion, a PE ratio of -423.71, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29. The company’s 50 day moving average price is $71.13 and its two-hundred day moving average price is $69.72. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. During the same period in the previous year, the firm posted $0.92 earnings per share. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ACHC shares. Barclays decreased their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. KeyCorp initiated coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Friday, September 20th. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $86.67.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.